About: Thomas P. Monath

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thomas P. Monath Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American physician, virologist and vaccine developer

Attributes	Values
rdf:type	Item
description	forskare (sv) 研究者 (ja) wetenschapper (nl) дослідник (uk) изилдөөчү (ky) 研究者 (zh) American physician, virologist and vaccine developer (en)
rdfs:label	Thomas P. Monath (en) Thomas P. Monath (nl) Thomas P. Monath (ast)
skos:prefLabel	Thomas P. Monath (en) Thomas P. Monath (nl) Thomas P. Monath (ast)
name	Thomas P. Monath (en) Thomas P. Monath (nl) Thomas P. Monath (ast)
Freebase ID	wds:Q59762392-C50D687A-2391-453E-ACC7-D037CEFDCF20
Freebase ID	/m/02h67_8
given name	wds:Q59762392-34EA12EC-34B9-4FDC-976B-CD7ED0B67803 wds:Q59762392-540bef49-41d1-1252-36a3-9ed25e94cc93
given name	Thomas P.
instance of	wds:Q59762392-C019843C-906D-4D89-A41C-0D11DCC9F45A
instance of	Homo sapiens
ResearchGate profile ID	wds:Q59762392-ace132c6-4d66-c88f-e559-0acf0a6e5eb5
ResearchGate profile ID	Thomas_Monath
skos:altLabel	Thomas Monath (en)
Nationale Thesaurus voor Auteursnamen ID	wds:Q59762392-e31f24fc-8b09-4a6f-8356-6d956322472b
occupation	wds:Q59762392-B9BBA52B-D2E9-4F57-BF45-5B164909AB04
sex or gender	wds:Q59762392-931a5d44-4baa-3eb0-673c-a1751263b41b
ISNI	wds:Q59762392-190a7a97-4d2c-67bc-c3c6-b455375829f6
VIAF ID	wds:Q59762392-4569388E-B8C3-4E57-AFC4-FA27129F4566
Library of Congress authority ID	wds:Q59762392-F721A5CD-FA2F-4531-9E1D-F5219AD6732E
IdRef ID	wds:Q59762392-b0314480-6dfa-4f87-9bbe-5dd2baa79d78
educated at	wds:Q59762392-9db810fc-13a9-4a48-8948-f844767840db
family name	wds:Q59762392-646d4bfe-4191-d5bf-80e4-3cc0eb9ca5d4
WorldCat Identities ID (superseded)	wds:Q59762392-11469121-2F91-4DEE-BEAD-63C93AEAC6B8
National Library of Israel J9U ID	wds:Q59762392-A42EE832-B0FD-4F0A-BD41-FAEE2248F9A8
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p07472746X
VIAF ID	http://viaf.org/viaf/36977771
Library of Congress authority ID	http://id.loc.gov/authorities/names/n80154924
IdRef ID	http://www.idref.fr/076151611/id
Nationale Thesaurus voor Auteursnamen ID	07472746X
occupation	researcher
sex or gender	male
ISNI	0000000022914218
VIAF ID	36977771
Library of Congress authority ID	n80154924
IdRef ID	076151611
educated at	Harvard Medical School
family name	Monath
WorldCat Identities ID (superseded)	lccn-n80154924
National Library of Israel J9U ID	987007339709705171
ORCID iD	wds:Q59762392-7CB92CD4-B8D1-408E-ACD4-CE557CA12EB8
ORCID iD	https://orcid.org/0000-0001-7509-4599
ORCID iD	0000-0001-7509-4599
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59762392
is author of	ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense Clonal vaccinia virus grown in cell culture as a new smallpox vaccine The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil High fidelity of yellow fever virus RNA polymerase Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis Attenuation of wild-type yellow fever virus by passage in HeLa cells Detection of Yellow Fever Virus in Serum by Enzyme Immunoassay * Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-hu Preface to volume 60 the flaviviruses: pathogenesis and immunity Epizootic vesicular stomatitis in Colorado, 1982: epidemiologic studies along the northern Colorado front range. Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates Recombination and flavivirus vaccines: a commentary Recent isolations of Lassa virus from Nigerian rodents Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1 Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis Traditional and novel approaches to flavivirus vaccines Pathogenesis and pathophysiology of yellow fever Yellow fever vaccine New developments in flavivirus vaccines with special attention to yellow fever Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes Genetic variation among dengue 2 viruses of different geographic origin Genetic heterogeneity among Saint Louis encephalitis virus isolates of different geographic origin Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Identification of a new Venezuelan equine encephalitis virus from Brazil. Venezuelan equine encephalomyelitis virus infection in and transmission by the tick Amblyomma cajennense (Arachnida: Ixodidae). Geographic variation among St. Louis encephalitis virus strains in the viremic responses of avian hosts Variation among strains of St. Louis encephalitis virus: basis for a genetic, pathogenetic, and epidemiologic classification A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report Dengue: the risk to developed and developing countries Epidemic yellow fever caused by an incompetent mosquito vector

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software